Edition:
India

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,830JPY
19 Jun 2018
Change (% chg)

¥-20 (-0.34%)
Prev Close
¥5,850
Open
¥5,840
Day's High
¥5,870
Day's Low
¥5,780
Volume
116,100
Avg. Vol
131,124
52-wk High
¥6,600
52-wk Low
¥5,430

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- March 19 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 2 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 4.00 3.50 3.50 3.50

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-18 2 99,750.00 100,200.00 99,300.00 --
Year Ending Mar-19 2 93,050.00 93,400.00 92,700.00 98,800.00
Year Ending Mar-20 2 93,100.00 93,200.00 93,000.00 99,900.00
Earnings (per share)
Year Ending Mar-18 2 490.65 491.10 490.20 --
Year Ending Mar-19 2 424.89 433.00 416.78 464.70
Year Ending Mar-20 2 425.98 437.60 414.37 474.62

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 21,845.00 20,249.00 1,596.00 7.31
Quarter Ending Dec-12 24,290.00 23,282.00 1,008.00 4.15
Quarter Ending Sep-12 22,719.00 22,742.00 23.00 0.10
Quarter Ending Jun-12 21,400.00 20,781.00 619.00 2.89

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-18 99,750.00 -- -- -- --
Year Ending Mar-19 93,050.00 93,050.00 95,500.00 96,200.00 98,800.00
Year Ending Mar-20 93,100.00 93,100.00 97,150.00 97,600.00 99,900.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 1
Year Ending Mar-20 0 0 0 1
Earnings